TrianglePUBLICATIONS · 19506160
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Aug 10
- First author
- Treon SP
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Treon SP
- type
- Author
- name
- Ioakimidis L
- type
- Author
- name
- Soumerai JD
- type
- Author
- name
- Patterson CJ
- type
- Author
- name
- Sheehy P
- type
- Author
- name
- Nelson M
- type
- Author
- name
- Willen M
- type
- Author
- name
- Matous J
- type
- Author
- name
- Mattern J 2nd
- type
- Author
- name
- Diener JG
- type
- Author
- name
- Keogh GP
- type
- Author
- name
- Myers TJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Treon SP
- type
- Author
- name
- Ioakimidis L
- type
- Author
- name
- Soumerai JD
- type
- Author
- name
- Patterson CJ
- type
- Author
- name
- Sheehy P
- type
- Author
- name
- Nelson M
- type
- Author
- name
- Willen M
- type
- Author
- name
- Matous J
- type
- Author
- name
- Mattern J 2nd
- type
- Author
- name
- Diener JG
- type
- Author
- name
- Keogh GP
- type
- Author
- name
- Myers TJ
- type
- Author
- bibliography ids
- nci-bib-5de3537fb60b67a6be53a076
- book metadata
- content sha256
- b65cb3c5af343a461168c987e1412cd65fc33a9c8d107354ae7f19ccdb252a28
- document type
- citation
- dois
- 10.1200/JCO.2008.20.4677
- electronic publication date
- display
- 2009 Jun 8
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19506160
- immutable id
- pubmed:19506160@b65cb3c5af343a461168c987e1412cd65fc33a9c8d107354ae7f19ccdb252a28
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 23
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3830-5
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19506160
- provenance
- batch id
- 4f803f1a8e7b4f56d2f1
- provider
- NCBI PubMed ESummary
- record sha256
- 7c273607a834ceee315e3531296d152a312a1a7cda116ef48b27a1c518a3de8e
- response sha256
- fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
- retrieved at
- 2026-09-09T23:46:26.391289+00:00
- publication date
- display
- 2009 Aug 10
- precision
- day
- year
- 2009
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
Preserved source evidence · Independent clinical review pending · Not medical advice